Mon, March 28, 2022
Sun, March 27, 2022
Fri, March 25, 2022
Thu, March 24, 2022

Paul Knight Maintained (XGN) at Buy with Decreased Target to $20 on, Mar 25th, 2022

Paul Knight of Keybanc, Maintained "Exagen Inc." (XGN) at Buy with Decreased Target from $30 to $20 on, Mar 25th, 2022.

Paul, nor any peers, have made any analyst calls on XGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30